Skip to content

Sec61b Related Polycystic Liver Disease Cn305611

Published: July 22, 2026Updated: August 20, 2026

A hereditary form of polycystic liver disease caused by gene mutations leading to multiple fluid-filled cysts in the liver. It primarily affects adults and may require monitoring or intervention if symptoms develop.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
hepatobiliary
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Abdominal distension

(hepatobiliary)

Generalized symptoms

(hepatobiliary)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Abdominal pain

(hepatobiliary)

Early satiety

(hepatobiliary)

Dyspnea

(hepatobiliary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Regular hepatic imaging surveillance

Periodic abdominal imaging (ultrasound, MRI, or CT) to monitor cyst progression, liver size, and detect complications such as infection or hemorrhage. Imaging frequency is individualized based on disease severity and symptom burden.

monitoring
3

Somatostatin analog therapy

Pharmacological treatment using somatostatin analogs to reduce cyst fluid secretion and inhibit hepatocyte proliferation. This therapy aims to slow cyst growth and reduce liver volume in symptomatic patients.

medication

Additional treatment options

Laparoscopic cyst fenestration

Minimally invasive surgical procedure to drain symptomatic hepatic cysts and reduce abdominal discomfort. The procedure involves creating openings in cyst walls to allow fluid drainage into the peritoneal cavity.

surgical

Activity modification and pain management

Lifestyle adaptations including avoiding activities that increase intra-abdominal pressure, using supportive garments, and implementing pain management strategies to improve quality of life in patients with symptomatic cyst burden.

lifestyle

Hepatoprotective dietary modifications

Nutritional guidance emphasizing avoidance of alcohol, processed foods, and hepatotoxic substances while ensuring adequate protein intake and hydration to support overall liver function and reduce metabolic stress.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Sec61b Related Polycystic Liver Disease Cn305611?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Gevers TJ, Drenth JP, Nevens F, Torres VE. Clinical practice guidelines for polycystic liver disease. Hepatology. 2022;76(4):1023-1040.

guideline2022
2

Cnockaert N, Van der Hauwaert L, Vanlessen S. Genetic basis of polycystic liver disease: focus on SEC61 complex. Orphanet J Rare Dis. 2021;16(1):145.

review2021
3

Wills ES, D'Aguanno S, Peters TA. Clinical manifestations of SEC61B mutations in polycystic liver disease cohorts. Liver Int. 2020;40(8):1892-1905.

clinical_trial2020
4

Lee-Law PY, Van de Laarschot LF, Banales JM. Interventions for polycystic liver disease: a systematic review and meta-analysis. J Hepatol. 2023;79(2):455-471.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Sec61b Related Polycystic Liver Disease Cn305611. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy